Serum Brevican as a Biomarker of Cerebrovascular Disease in an Elderly Cognitively Impaired Cohort
Authors:
- Rachel S. L. ChiaRCRachel S. L. Chia
- Karolina MintaKMKarolina Minta
- Liu-Yun WuLWLiu-Yun Wu
- Kaung H. T. SalaiKSKaung H. T. Salai
- Yuek Ling ChaiYCYuek Ling Chai
- Saima HilalSHSaima Hilal
- Narayanaswamy VenketasubramanianNarayanaswamy Venketasubramanian
- Christopher P. ChenCCChristopher P. Chen
- Joyce R. ChongJCJoyce R. Chong
- Mitchell K. P. LaiMLMitchell K. P. Lai
Open Access
- 7 January 2024
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 14 (1) , 75
Abstract
In the brain, the extracellular matrix (ECM) composition shapes the neuronal microenvironment and can undergo substantial changes with cerebral pathology. Brevican is integral to the formation of the ECM’s neuroprotective perineuronal nets (PNNs). Decreased brevican levels were reported in vascular dementia (VaD) but not in Alzheimer’s disease (AD). However, the status of brevican in clinical cohorts with high concomitance of AD pathological burden and cerebrovascular disease (CeVD) is unclear. In this study, 32 non-cognitively impaired (NCI), 97 cognitively impaired no dementia (CIND), 46 AD, and 23 VaD participants recruited from memory clinics based in Singapore underwent neuropsychological and neuroimaging assessments, together with measurements of serum brevican. Association analyses were performed between serum brevican and neuroimaging measures of CeVDs, including white matter hyperintensities (WMHs), lacunes, cortical infarcts, and cerebral microbleeds. Using an aggregated score for CeVD burden, only CIND participants showed lower brevican levels with higher CeVD compared to those with lower CeVD burden (p = 0.006). Among the CeVD subtypes assessed, only elevated WMH burden was associated with lower brevican levels (OR = 2.7; 95% CI = 1.3–5.5). Our findings suggest that brevican deficits may play a role in early cerebrovascular damage in participants at risk of developing dementia.Keywords
Funding Information
- National Medical Research Council (MOH-000707-01, NMRC/CG/M006/2017, HLTRP/2022/PS-01, NUSMED/2021/PDF/05)
- NUS Healthy Longevity Translational Research Programme (MOH-000707-01, NMRC/CG/M006/2017, HLTRP/2022/PS-01, NUSMED/2021/PDF/05)
- Yong Loo Lin School of Medicine (MOH-000707-01, NMRC/CG/M006/2017, HLTRP/2022/PS-01, NUSMED/2021/PDF/05)
This publication has 50 references indexed in Scilit:
- Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancerDisease Models & Mechanisms, 2011
- Chondroitin sulfate reduces cell death of rat hippocampal slices subjected to oxygen and glucose deprivation by inhibiting p38, NFκB and iNOSNeurochemistry International, 2011
- The overlap between neurodegenerative and vascular factors in the pathogenesis of dementiaActa Neuropathologica, 2010
- Accuracy and reproducibility study of automatic MRI brain tissue segmentation methodsNeuroImage, 2010
- Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular diseaseBiochemical Pharmacology, 2008
- Multi-spectral brain tissue segmentation using automatically trained k-Nearest-Neighbor classificationNeuroImage, 2007
- Brevican and phosphacan expression and localization following transient middle cerebral artery occlusion in the ratBiochemical Society Transactions, 2007
- Matrix metalloproteinases in peripheral vascular diseaseJournal of Vascular Surgery, 2007
- Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementiaInternational Psychogeriatrics, 2007
- Alzheimer disease and cerebrovascular pathology: an updateJournal of Neural Transmission, 2002